CompletedNANCT04865341

Optimizing an IMB-guided Intervention to Support HIV Self-testing and PrEP Uptake Among YMSM: A Pilot Randomized Controlled Trial

Sponsor: Medical College of Wisconsin

Trial Details

ConditionHuman Immunodeficiency Virus
InterventionIMB; Information-Only Control
PhaseNA
StatusCompleted
Participants118
Est. Completion31 Aug 2024
Last Updated1 May 2026

Primary Outcome

Number of Participants With Self-reported Self-administration of HIV Testing; Number of Participants With Self-reported PrEP Uptake

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. 17-24 years old; 2. Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months; 3. Resident of the US based on home address; 4. HIV-negative or unknown status based on self-report; and 5. Self-reported risk for HIV (based on CDC criteria for PrEP use) defined as reporting any of the following in the past six months: 1. Bacterial STI 2. Condomless anal sex (CAS) with a casual male sexual partner 3. CAS with an HIV-positive or unknown status main partner 4. CAS with an HIV-negative main partner who reports CAS with other male partners. Exclusion Criteria: 1. Current PrEP use; 2. Unstable, serious psychiatric symptoms; 3. Currently suicidal/homicidal; and 4. Evidence of gross cognitive impairment.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service